Quantitative Investment Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
Sell
-4,200
Closed -$440K 605
2014
Q2
$440K Sell
4,200
-6,400
-60% -$670K 0.08% 249
2014
Q1
$879K Buy
+10,600
New +$879K 0.04% 267